Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections
Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii)...
Gespeichert in:
Veröffentlicht in: | Journal of inorganic biochemistry 2015-11, Vol.152, p.199-205 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 205 |
---|---|
container_issue | |
container_start_page | 199 |
container_title | Journal of inorganic biochemistry |
container_volume | 152 |
creator | Crépeaux, Guillemette Eidi, Housam David, Marie-Odile Tzavara, Eleni Giros, Bruno Exley, Christopher Curmi, Patrick A. Shaw, Christopher A. Gherardi, Romain K. Cadusseau, Josette |
description | Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants.
[Display omitted]
•Vaccine safety is a key question due to the reported adverse events in humans & animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure & doses.•This study confirms the striking biopersistence of alum. |
doi_str_mv | 10.1016/j.jinorgbio.2015.07.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02292714v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0162013415300313</els_id><sourcerecordid>1749998667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</originalsourceid><addsrcrecordid>eNqFkUGv1CAUhYnR-Manf0FZ6qIVCi1lOZmnjskkbnRNKNzOo6HwhHbM_HuZzHO2rgg33zkH7kHoAyU1JbT7PNWTCzEdBxfrhtC2JqImhL9AG9oLVjHG-Uu0KWRTEcr4HXqT80QIaVsuXqO7pmM950xsUNy746M_Ywten8HifM4LzM7gJemQfTR6cTHgOGLt19mFda4GnQuo7bSedFiwC3j3QHHRAB6j9_GPC8cyLQbzms3qdSq3CczFKL9Fr0btM7x7Pu_Rr69ffu721eHHt--77aEynLRLJQcYDMiRDGKwA0hLpeylpGNvRSO60VLetZLb8merRzCEMdKWWdfrHjpL2D36dPV91F49JTfrdFZRO7XfHtRlRppGNoLyEy3sxyv7lOLvFfKiZpcNeK8DxDUrKrgs8V0nCiquqEkx5wTjzZsSdWlGTerWjLo0o4hQ5ZVF-f45ZB1msDfdvyoKsL0CUNZycpBUNg6CAetSWZ6y0f035C97zqVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749998667</pqid></control><display><type>article</type><title>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Crépeaux, Guillemette ; Eidi, Housam ; David, Marie-Odile ; Tzavara, Eleni ; Giros, Bruno ; Exley, Christopher ; Curmi, Patrick A. ; Shaw, Christopher A. ; Gherardi, Romain K. ; Cadusseau, Josette</creator><creatorcontrib>Crépeaux, Guillemette ; Eidi, Housam ; David, Marie-Odile ; Tzavara, Eleni ; Giros, Bruno ; Exley, Christopher ; Curmi, Patrick A. ; Shaw, Christopher A. ; Gherardi, Romain K. ; Cadusseau, Josette</creatorcontrib><description>Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants.
[Display omitted]
•Vaccine safety is a key question due to the reported adverse events in humans & animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure & doses.•This study confirms the striking biopersistence of alum.</description><identifier>ISSN: 0162-0134</identifier><identifier>EISSN: 1873-3344</identifier><identifier>DOI: 10.1016/j.jinorgbio.2015.07.004</identifier><identifier>PMID: 26384437</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adjuvants, Immunologic - administration & dosage ; Adjuvants, Immunologic - blood ; Adjuvants, Immunologic - toxicity ; Alum ; Aluminum Compounds - administration & dosage ; Aluminum Compounds - blood ; Aluminum Compounds - toxicity ; Animals ; CD1 mice ; Delayed-translocation ; Female ; Fluorescent-nanodiamonds ; Granuloma - etiology ; Injections, Intramuscular ; Life Sciences ; Mice ; Neurons and Cognition ; Neurotoxicity ; Species Specificity ; Vaccine-adjuvant</subject><ispartof>Journal of inorganic biochemistry, 2015-11, Vol.152, p.199-205</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</citedby><cites>FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</cites><orcidid>0000-0001-7624-3904 ; 0000-0002-4543-7818 ; 0000-0001-5045-8501 ; 0000-0001-5876-9822</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0162013415300313$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26384437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-evry.hal.science/hal-02292714$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Crépeaux, Guillemette</creatorcontrib><creatorcontrib>Eidi, Housam</creatorcontrib><creatorcontrib>David, Marie-Odile</creatorcontrib><creatorcontrib>Tzavara, Eleni</creatorcontrib><creatorcontrib>Giros, Bruno</creatorcontrib><creatorcontrib>Exley, Christopher</creatorcontrib><creatorcontrib>Curmi, Patrick A.</creatorcontrib><creatorcontrib>Shaw, Christopher A.</creatorcontrib><creatorcontrib>Gherardi, Romain K.</creatorcontrib><creatorcontrib>Cadusseau, Josette</creatorcontrib><title>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</title><title>Journal of inorganic biochemistry</title><addtitle>J Inorg Biochem</addtitle><description>Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants.
[Display omitted]
•Vaccine safety is a key question due to the reported adverse events in humans & animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure & doses.•This study confirms the striking biopersistence of alum.</description><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Adjuvants, Immunologic - blood</subject><subject>Adjuvants, Immunologic - toxicity</subject><subject>Alum</subject><subject>Aluminum Compounds - administration & dosage</subject><subject>Aluminum Compounds - blood</subject><subject>Aluminum Compounds - toxicity</subject><subject>Animals</subject><subject>CD1 mice</subject><subject>Delayed-translocation</subject><subject>Female</subject><subject>Fluorescent-nanodiamonds</subject><subject>Granuloma - etiology</subject><subject>Injections, Intramuscular</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Neurons and Cognition</subject><subject>Neurotoxicity</subject><subject>Species Specificity</subject><subject>Vaccine-adjuvant</subject><issn>0162-0134</issn><issn>1873-3344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUGv1CAUhYnR-Manf0FZ6qIVCi1lOZmnjskkbnRNKNzOo6HwhHbM_HuZzHO2rgg33zkH7kHoAyU1JbT7PNWTCzEdBxfrhtC2JqImhL9AG9oLVjHG-Uu0KWRTEcr4HXqT80QIaVsuXqO7pmM950xsUNy746M_Ywten8HifM4LzM7gJemQfTR6cTHgOGLt19mFda4GnQuo7bSedFiwC3j3QHHRAB6j9_GPC8cyLQbzms3qdSq3CczFKL9Fr0btM7x7Pu_Rr69ffu721eHHt--77aEynLRLJQcYDMiRDGKwA0hLpeylpGNvRSO60VLetZLb8merRzCEMdKWWdfrHjpL2D36dPV91F49JTfrdFZRO7XfHtRlRppGNoLyEy3sxyv7lOLvFfKiZpcNeK8DxDUrKrgs8V0nCiquqEkx5wTjzZsSdWlGTerWjLo0o4hQ5ZVF-f45ZB1msDfdvyoKsL0CUNZycpBUNg6CAetSWZ6y0f035C97zqVQ</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Crépeaux, Guillemette</creator><creator>Eidi, Housam</creator><creator>David, Marie-Odile</creator><creator>Tzavara, Eleni</creator><creator>Giros, Bruno</creator><creator>Exley, Christopher</creator><creator>Curmi, Patrick A.</creator><creator>Shaw, Christopher A.</creator><creator>Gherardi, Romain K.</creator><creator>Cadusseau, Josette</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7624-3904</orcidid><orcidid>https://orcid.org/0000-0002-4543-7818</orcidid><orcidid>https://orcid.org/0000-0001-5045-8501</orcidid><orcidid>https://orcid.org/0000-0001-5876-9822</orcidid></search><sort><creationdate>201511</creationdate><title>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</title><author>Crépeaux, Guillemette ; Eidi, Housam ; David, Marie-Odile ; Tzavara, Eleni ; Giros, Bruno ; Exley, Christopher ; Curmi, Patrick A. ; Shaw, Christopher A. ; Gherardi, Romain K. ; Cadusseau, Josette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-9bebce9f0b7bdbe9d1998991f8d7276fd146594d004dafec0330514668a8e6d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Adjuvants, Immunologic - blood</topic><topic>Adjuvants, Immunologic - toxicity</topic><topic>Alum</topic><topic>Aluminum Compounds - administration & dosage</topic><topic>Aluminum Compounds - blood</topic><topic>Aluminum Compounds - toxicity</topic><topic>Animals</topic><topic>CD1 mice</topic><topic>Delayed-translocation</topic><topic>Female</topic><topic>Fluorescent-nanodiamonds</topic><topic>Granuloma - etiology</topic><topic>Injections, Intramuscular</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Neurons and Cognition</topic><topic>Neurotoxicity</topic><topic>Species Specificity</topic><topic>Vaccine-adjuvant</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crépeaux, Guillemette</creatorcontrib><creatorcontrib>Eidi, Housam</creatorcontrib><creatorcontrib>David, Marie-Odile</creatorcontrib><creatorcontrib>Tzavara, Eleni</creatorcontrib><creatorcontrib>Giros, Bruno</creatorcontrib><creatorcontrib>Exley, Christopher</creatorcontrib><creatorcontrib>Curmi, Patrick A.</creatorcontrib><creatorcontrib>Shaw, Christopher A.</creatorcontrib><creatorcontrib>Gherardi, Romain K.</creatorcontrib><creatorcontrib>Cadusseau, Josette</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of inorganic biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crépeaux, Guillemette</au><au>Eidi, Housam</au><au>David, Marie-Odile</au><au>Tzavara, Eleni</au><au>Giros, Bruno</au><au>Exley, Christopher</au><au>Curmi, Patrick A.</au><au>Shaw, Christopher A.</au><au>Gherardi, Romain K.</au><au>Cadusseau, Josette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections</atitle><jtitle>Journal of inorganic biochemistry</jtitle><addtitle>J Inorg Biochem</addtitle><date>2015-11</date><risdate>2015</risdate><volume>152</volume><spage>199</spage><epage>205</epage><pages>199-205</pages><issn>0162-0134</issn><eissn>1873-3344</eissn><abstract>Concerns regarding vaccine safety have emerged following reports of potential adverse events in both humans and animals. In the present study, alum, alum-containing vaccine and alum adjuvant tagged with fluorescent nanodiamonds were used to evaluate i) the persistence time at the injection site, ii) the translocation of alum from the injection site to lymphoid organs, and iii) the behavior of adult CD1 mice following intramuscular injection of alum (400μgAl/kg). Results showed for the first time a strikingly delayed systemic translocation of adjuvant particles. Alum-induced granuloma remained for a very long time in the injected muscle despite progressive shrinkage from day 45 to day 270. Concomitantly, a markedly delayed translocation of alum to the draining lymph nodes, major at day 270 endpoint, was observed. Translocation to the spleen was similarly delayed (highest number of particles at day 270). In contrast to C57BL/6J mice, no brain translocation of alum was observed by day 270 in CD1 mice. Consistently neither increase of Al cerebral content, nor behavioral changes were observed. On the basis of previous reports showing alum neurotoxic effects in CD1 mice, an additional experiment was done, and showed early brain translocation at day 45 of alum injected subcutaneously at 200μgAl/kg. This study confirms the striking biopersistence of alum. It points out an unexpectedly delayed diffusion of the adjuvant in lymph nodes and spleen of CD1 mice, and suggests the importance of mouse strain, route of administration, and doses, for future studies focusing on the potential toxic effects of aluminum-based adjuvants.
[Display omitted]
•Vaccine safety is a key question due to the reported adverse events in humans & animals.•Results showed a highly delayed systemic translocation of adjuvant particles.•This study suggests the importance of mouse strain, route of exposure & doses.•This study confirms the striking biopersistence of alum.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26384437</pmid><doi>10.1016/j.jinorgbio.2015.07.004</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-7624-3904</orcidid><orcidid>https://orcid.org/0000-0002-4543-7818</orcidid><orcidid>https://orcid.org/0000-0001-5045-8501</orcidid><orcidid>https://orcid.org/0000-0001-5876-9822</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0162-0134 |
ispartof | Journal of inorganic biochemistry, 2015-11, Vol.152, p.199-205 |
issn | 0162-0134 1873-3344 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_02292714v1 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adjuvants, Immunologic - administration & dosage Adjuvants, Immunologic - blood Adjuvants, Immunologic - toxicity Alum Aluminum Compounds - administration & dosage Aluminum Compounds - blood Aluminum Compounds - toxicity Animals CD1 mice Delayed-translocation Female Fluorescent-nanodiamonds Granuloma - etiology Injections, Intramuscular Life Sciences Mice Neurons and Cognition Neurotoxicity Species Specificity Vaccine-adjuvant |
title | Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T15%3A05%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Highly%20delayed%20systemic%20translocation%20of%20aluminum-based%20adjuvant%20in%20CD1%20mice%20following%20intramuscular%20injections&rft.jtitle=Journal%20of%20inorganic%20biochemistry&rft.au=Cr%C3%A9peaux,%20Guillemette&rft.date=2015-11&rft.volume=152&rft.spage=199&rft.epage=205&rft.pages=199-205&rft.issn=0162-0134&rft.eissn=1873-3344&rft_id=info:doi/10.1016/j.jinorgbio.2015.07.004&rft_dat=%3Cproquest_hal_p%3E1749998667%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1749998667&rft_id=info:pmid/26384437&rft_els_id=S0162013415300313&rfr_iscdi=true |